CPPD study for acute and chronic forms
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at calcium pyrophosphate deposition (CPPD) disease, which causes joint inflammation. It aims to understand the disease better by studying people with either an acute first episode or ongoing chronic CPPD arthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had your first acute CPPD attack as part of another study, OR
- You are 65 or older and have been diagnosed with chronic CPPD arthritis by a rheumatologist
- Your CPPD has been active for at least 3 months, with a pain or activity score of 40 or more on a 100-point scale, or have had at least one flare in the last 3 months
- You have adequate kidney function (eGFR of 30 or higher)
- You have not taken certain arthritis medications within 2 weeks to 3 months before joining, depending on the drug
- You are covered by French social security and can give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tocilizumab can help people with chronic pain from CPPD crystal arthritis (also called pseudogout). It is for people whose pain has not responded to usual treatments like colchicine, NSAIDs, or steroids.
This study tests if baricitinib, an anti-inflammatory pill, can help people with arthritis caused by CPPD crystals (also called pseudogout). It is for people aged 55 and older who have swelling in their hands/wrists or large joints.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study looks at people with certain types of crystal deposits in joints (like gout, CPPD, or hydroxyapatite crystal disease). It uses scans such as ultrasound and a special CT-type scan called DECT to confirm and better understand what’s causing your symptoms.
This study follows people with a first episode of peripheral (hand/foot/arm/leg) arthritis that seems to be psoriatic arthritis. It aims to improve understanding of early disease and may help guide more personalized care over time.
This study looks at patients who have been recently diagnosed with polymyalgia rheumatica (PPR) and are starting steroid treatment. It aims to understand how the disease progresses over time.
Hear when a new Calcium Pyrophosphate Deposition Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.